Finally, the combination of differential expression and differential coexpression analyses has allowed the identification of miR-20b, miR-331-5p, miR-1246 and SNORA40 as potential theraputic targets in multiple sclerosis, SNORA40 being the promising candidate. This evidence concerns the gene SNORA40 and multiple sclerosis.